Crossing a New Threshold : Use of Elevated (1,3)-β-d- Glucan Levels to Distinguish Causation From Colonization in Pneumocystis jirovecii Polymerase Chain Reaction-Positive Cancer Patients
| Errataetall: |
CommentOn: Clin Infect Dis. 2019 Sep 27;69(8):1303-1309. - PMID 30561560 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 69(2019), 8 vom: 27. Sept., Seite 1310-1312 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Theel, Elitza S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
β-d-glucan |
|---|
| Anmerkungen: |
Date Completed 12.05.2020 Date Revised 12.05.2020 published: Print CommentOn: Clin Infect Dis. 2019 Sep 27;69(8):1303-1309. - PMID 30561560 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciy1078 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM291913172 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM291913172 | ||
| 003 | DE-627 | ||
| 005 | 20231225071926.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciy1078 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0973.xml |
| 035 | |a (DE-627)NLM291913172 | ||
| 035 | |a (NLM)30561566 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Theel, Elitza S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Crossing a New Threshold |b Use of Elevated (1,3)-β-d- Glucan Levels to Distinguish Causation From Colonization in Pneumocystis jirovecii Polymerase Chain Reaction-Positive Cancer Patients |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.05.2020 | ||
| 500 | |a Date Revised 12.05.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Clin Infect Dis. 2019 Sep 27;69(8):1303-1309. - PMID 30561560 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Pneumocystis jirovecii | |
| 650 | 4 | |a immunocompromised host | |
| 650 | 4 | |a β-d-glucan | |
| 650 | 7 | |a beta-Glucans |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 69(2019), 8 vom: 27. Sept., Seite 1310-1312 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2019 |g number:8 |g day:27 |g month:09 |g pages:1310-1312 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciy1078 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2019 |e 8 |b 27 |c 09 |h 1310-1312 | ||